Research of the Relationship of Aspirin Resistance and Platelet Membrane Glycoprotein CD62p,CD63 and GPIIb IIIa in Patients with Ischemic Stroke
Xiaoyan He
Abstract
Xiaoyan He
Abstract
Objective:To investigate the relationship between changes of platelet membrane glycoprotein CD62p,CD63 and GP Ⅱ b / Ⅲ a and aspirin resistance the patients with ischemic stroke.Method:We randomly selected 60 cases with ischemic stroke and 30 cases physical health of the same period from Jan.2009 to Dec.2010 in our hospital.Positive expression rate of CD62p,CD63 and GP Ⅱb/Ⅲ were detervmined by FCM in the crowd.60 cases received aspirin(100mg,qd) for 2 weeks,then given flow cytometry test.They were divided into aspirin resistance group(AR group) and aspirin-sensitive group(AS group),and AR group had 8 cases while AS group had 52 cases.The 30 healthy people were considered as the control group.Determined the positive expression rate of D62p,CD63 and GP Ⅱ b / Ⅲ in the three groups.Results:① The positive expression rate of CD62p,CD63 and GPⅡb / Ⅲ in 60 patients was significantly lower than those of before the treatment,however,it was higher than the control group,there were statistically significant differences between the data(P0.01).② AR group of patients with platelet GP Ⅱ b / Ⅲ a expression was higher than which was in the AS group(P 0.01).Conclusion:GP Ⅱ b / Ⅲ a can be used as the reference of ischemic stroke patients treated with aspirin early.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the relationship between changes of platelet membrane glycoprotein CD62p,CD63 and GP Ⅱ b / Ⅲ a and aspirin resistance the patients with ischemic stroke.Method:We randomly selected 60 cases with ischemic stroke and 30 cases physical health of the same period from Jan.2009 to Dec.2010 in our hospital.Positive expression rate of CD62p,CD63 and GP Ⅱb/Ⅲ were detervmined by FCM in the crowd.60 cases received aspirin(100mg,qd) for 2 weeks,then given flow cytometry test.They were divided into aspirin resistance group(AR group) and aspirin-sensitive group(AS group),and AR group had 8 cases while AS group had 52 cases.The 30 healthy people were considered as the control group.Determined the positive expression rate of D62p,CD63 and GP Ⅱ b / Ⅲ in the three groups.Results:① The positive expression rate of CD62p,CD63 and GPⅡb / Ⅲ in 60 patients was significantly lower than those of before the treatment,however,it was higher than the control group,there were statistically significant differences between the data(P0.01).② AR group of patients with platelet GP Ⅱ b / Ⅲ a expression was higher than which was in the AS group(P 0.01).Conclusion:GP Ⅱ b / Ⅲ a can be used as the reference of ischemic stroke patients treated with aspirin early.
Key concepts: Aspirin, Medicine, CD63, Platelet membrane glycoprotein, Platelet, Platelet activation, Ischemic stroke, Internal medicine